Patents Assigned to Central Laboratory of the Swiss Red Cross Blood Transfusion Service
  • Treatment of chronic inflammatory disease with polyvalent immunoglobulins
    Patent number: 4676982
    Abstract: Chronic inflammatory disease of the bowel, e.g. ulcerative colitis and Cr's disease, is treated by infusion of an intravenously injectable form of a polyvalent, intact immunoglobulin (IgG).
    Type: Grant
    Filed: August 4, 1986
    Date of Patent: June 30, 1987
    Assignee: Central Laboratory of the Swiss Red Cross Blood Transfusion Service
    Inventor: Alfred Hassig